Altamira Therapeutics Ltd.: xbrl:AdjustmentsForFairValueGainsLosses
| Value | {"amount": -14917, "currency": "USD"} |
|---|---|
| Period | (as of 2025-05-19) |
| Status | current |
| Entity | Altamira Therapeutics Ltd. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/7ae4eb96-2d34-4abc-b1bb-64ad0e2e180c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-25-082071Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Cite as: FACTANKER, https://factanker.com/fact/7ae4eb96-2d34-4abc-b1bb-64ad0e2e180c
History
- no predecessors — first report